Conflict of interest declaration: Stefan Leucht

Roles in: Schizophrenia Group

1. In the past three years have you accepted the following from an organisation that may gain or lose financially from the publication of reviews by your review group in the Cochrane Database of Systematic Reviews (CDSR)?

a) Reimbursement for attending a conference or symposium (including travel, accommodation and/or hospitality)?
No

b) Fees for speaking?
Yes - EliLilly, Lundbeck, Pfizer, Janssen, BMS, Janssen, Johnson and Johnson, Lundbeck, Otsuka, Roche, SanofiAventis, ICON, Abbvie

c) Fees for organising education?
No

d) Funds for research?
Yes - EliLilly has provided medication for a clinical trial led by SL as principal investigator

e) Funds for a member of staff?
No

f) Fees for consulting?
Yes - Roche, Janssen, Lundbeck, EliLilly, Otsuka

g) Royalty payments?
No

2. In the past three years have you or your spouse/partner been employed by an organization that may in any way gain or lose financially from the publication of reviews by your review group in the CDSR?
No

3. Do you own stocks or shares in companies that may gain or lose financially from the publication of reviews by your review group in the CDSR?
No

4. Do you hold any patents for products that that may lead you to gain or lose financially from the publication of reviews by your review group in the CDSR?
No

5. Do you have any other competing interests (financial or non-financial)?
Yes - Fees for preparation of educational material and publications from Lundbeck Institute and Roche